Drugs / mRNA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05568693 | Sep → Oct 2022 | COVID-19 | Yu Qin | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05568693 ↗ |
| Modality | Messenger RNA (mRNA) | “Novel Coronavirus Messenger RNA (mRNA) Vaccine” NCT05568693 ↗ |
| Route | Intramuscular | “Subjects received 0.3ml of mRNA vaccine intramuscularly” NCT05568693 ↗ |